Richard E. Lowenthal

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Diego, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Kathleen Scott, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Richard E. Lowenthal

Form 4 holding PRESIDENT AND CEO, Director, 10%+ Owner

ARS Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
8,859,200
Estimated value
$162,566,320
Report date
21 Aug 2025
Price
$18.35
Ownership
By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006
Form 4 holding PRESIDENT AND CEO, Director, 10%+ Owner

ARS Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
1,247,447
Estimated value
$22,890,652
Report date
21 Aug 2025
Price
$18.35
Ownership
By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 2020
Form 4 holding PRESIDENT AND CEO, Director, 10%+ Owner

ARS Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
1,196,494
Estimated value
$17,333,488
Report date
21 Aug 2025
Price
$14.49
Ownership
By Richard E. Lowenthal Charitable Remainder UniTrust Dated January 7, 2020
Form 4 holding PRESIDENT AND CEO, Director, 10%+ Owner

ARS Pharmaceuticals, Inc.

Security class
Stock option (right to buy)
Shares / value
875,000
Estimated value
Report date
02 Jan 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding PRESIDENT AND CEO, Director, 10%+ Owner

ARS Pharmaceuticals, Inc.

Security class
Stock Option (right to buy)
Shares / value
240,000
Estimated value
Report date
02 Jan 2026
Price
Ownership
By Spouse
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Richard E. Lowenthal

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .